Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
Brandon K MartinezWilliam L BakerNitesh A SoodThomas J BunzAnna-Katharina MeineckeDaniel ErikssonCraig I ColemanPublished in: Pharmacotherapy (2019)
This real-world study suggests that in the setting of polypharmacy and NVAF, rivaroxaban is an effective and safe alternative to warfarin.